Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
663
+7
+1% +$2.4K 0.03% 127
2026
Q1
$231K Sell
656
-119
-15% -$42.4K 0.03% 126
2025
Q4
$254K Buy
775
+39
+5% +$12.4K 0.04% 117
2025
Q3
$208K Buy
736
+16
+2% +$4.64K 0.03% 125
2025
Q2
$201K Buy
+720
New +$204K 0.03% 120

Other funds holding AMGN

Burton Enright Welch's AMGN Position: Q2 2026 in Review

Burton Enright Welch increased its Amgen (AMGN) stake by 1.1% in Q2 2026, buying an estimated $2.4K and bringing the position to 663 shares worth $240K. The position accounts for 0.03% of the portfolio, ranked #127.

Burton Enright Welch first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $254K in Q4 2025. 953 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Burton Enright Welch held 663 shares of Amgen worth $240K as of Q2 2026.
  • Burton Enright Welch bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.03% of Burton Enright Welch's portfolio in Q2 2026, its #127 holding.
  • Burton Enright Welch first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • Burton Enright Welch's Amgen position peaked at $254K in Q4 2025.
  • 953 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Burton Enright Welch's 13F filing for Q2 2026, filed 17 Jul 2026.